Teglicar

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTeglicar
Drug Alias Name替格列卡teglicarumteglicarST-1326
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarnitine palmitoyltransferase 1A inhibitors
TargetsCarnitine palmitoyltransferase 1A
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Spa
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A